Loewen Andrea 4
4 · REATA PHARMACEUTICALS INC · Filed Mar 6, 2023
Insider Transaction Report
Form 4
Loewen Andrea
SVP, Global Regulatory Affairs
Transactions
- Sale
Class A common stock
2023-03-02$90.61/sh−218$19,753→ 44,394 total - Sale
Class A common stock
2023-03-03$87.73/sh−1,601$140,456→ 42,793 total
Footnotes (3)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $90.59 to $90.6181. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.71 to $87.78. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.